TheHeart.org reported today that experts speaking at the European Meeting on Hypertension 2012 this past weekend admitted there is much that remains unknown in the field hypertension. Evidence for seemingly straightforward issues, such as what should be the ideal number to lower blood pressure to in different groups of individuals, is lacking and many new trials need to be performed. In the meantime, guidelines need to offer the best direction they can for those who have the task of treating hypertension.
Hypertension poses a significant risk to women. An increase in the overall rates of obesity and diabetes have led to more uncontrolled hypertension, which in turn leads to numerous complications which often require revascularization. As it relates to women, after the age of 55, they are at an increased risk for hypertension when compared to men and yet are less likely to receive revascularization. With a growing patient population experiencing hypertension, physicians need to be aware of how to address it appropriately, especially in their female patients.
WIN is putting a focus on this subject matter, conducting a symposia series around hypertension and atrial fibrillation. A lunch program was held during TCT 2011, and another is planned for ESC 2012. The goal is to educate the interventional cardiology community on how to best address uncontrolled hypertension in the female population.
Part of WIN’s mission is to increase the number of women in the field of interventional cardiology. The goal is not only to assist female physicians in fulfilling their own professional goals, but to assist in diversifying the cardiology workforce (in which women are woefully underrepresented). WIN’s belief is that a more diverse workforce will allow for a diversified and effective approach to the care of different patient populations. Specifically, a more effective approach to the diagnosis and treatment of women with heart disease.